Envoy Medical's global patent portfolio now consists of: 35 pending applications (26 foreign and 9 U.S.) The foreign patent ...
With a trillion-dollar market cap and a wildly successful GLP-1 portfolio, Eli Lilly isn’t resting on its laurels. At the ...
As Big Pharma adds AI technology to bolster drug development, a cadre of new, upstart biotechs are pushing drug discovery to ...
The awards are subject to all terms and conditions and other provisions set forth in the Company’s 2022 Inducement Equity ...
$12.5 million in support to build talent pipeline, workforce training center with San Jacinto College ...
Silver Spring, MD, Sept. 21, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued a direct final rule ...
Rutika Mehta, MD, MPH, a nationally recognized gastrointestinal (GI) medical oncologist, has joined NYU Langone Health's ...
The Evident Ovarian Cancer Screening Test is powered by Mercy's patented Mercy Halo™ liquid biopsy platform, which uses ...
Award supports development of automated clinical consistency checking to strengthen safety monitoring across trial data ...
The mid-stage readout is one link in a chain of catalysts that analysts were watching for this year from Roche’s metabolic pipeline, which features assets from the $2.7 billion acquisition of Carmot ...
Novo CEO Maziar Mike Doustdar disclosed an additional 4,000 staff departures, which a spokesperson told BioSpace are linked to attrition and other measures.
Viking Therapeutics’ VK2735 met Truist’s “best-case scenario,” with robust weight loss that was largely maintained when patients transitioned to less frequent dosing. Viking’s stock popped more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results